Omeros | OMER - Market Capitalization


Omeros reported $1.07B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.7B 757M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
BioMarin Pharmaceutical USD 10.95B 667M Nov/2026
Cytokinetics USD 7.51B 1.66B Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
MacroGenics USD 151M 143M Nov/2026
Pacira USD 1.69B 695M Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
Vertex Pharmaceuticals USD 142.88B 10.37B Nov/2026